Ghandari Gunjana MD Battle Creek, MI - 49017

Ghandari Gunjana MD is categorized under Internal Medicine Doctors in Battle Creek, MI and active since 2010.

Ghandari Gunjana MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Gunjana Ghandari at the company’s single location by writing to 632 North Avenue, Battle Creek, Michigan MI 49017 or by phoning (269) 969-6145. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Ghandari Gunjana MD
Contact Person: Gunjana Ghandari
Address: 632 North Avenue, Battle Creek, Michigan 49017
Phone Number: (269) 969-6145
Website Address: physicians.battlecreek.ypeek.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Ghandari Gunjana MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Gunjana Ghandari for inquiries that concern Ghandari Gunjana MD by calling the company number (269) 969-6145, as your correspondence is most welcome. Additionally, the physical location of the single location of Ghandari Gunjana MD can be found at the coordinates 42.34049,-85.1805 as well as the street address 632 North Avenue in Battle Creek, Michigan 49017.

For its online presence, you may visit Ghandari Gunjana MD’s website at physicians.battlecreek.ypeek.com and engage with its social media outlets through on Twitter and on Facebook.